https://efbapharma.my/blog/ Regulation and science for licensed suppliers. en-MY Mon, 02 Nov 2026 03:00:00 +0000 https://efbapharma.my/assets/img/blog/nad-plus-molecule-science-evidence-cover.webp https://efbapharma.my/blog/ https://efbapharma.my/blog/nad-plus-molecule-science-evidence/ https://efbapharma.my/blog/nad-plus-molecule-science-evidence/ Mon, 02 Nov 2026 03:00:00 +0000 Molecule science NAD+ as a coenzyme and an enzyme substrate, four biosynthetic routes, the human trials of NR and NMN, and the thin literature on intravenous NAD+, with the limits of each study stated. https://efbapharma.my/blog/medicine-advertising-rules-malaysia-act-290-mab/ https://efbapharma.my/blog/medicine-advertising-rules-malaysia-act-290-mab/ Mon, 02 Nov 2026 02:30:00 +0000 Regulation A summary of Act 290 for suppliers: the broad definition of an advertisement, prohibited and approval-only claims, offences and presumptions, and the narrow defences available to a person charged. https://efbapharma.my/blog/npra-registration-import-injectable-vitamins-malaysia/ https://efbapharma.my/blog/npra-registration-import-injectable-vitamins-malaysia/ Mon, 02 Nov 2026 02:00:00 +0000 Regulation The Product Registration Holder, the ASEAN dossier, certificates for imported products, GMP evidence, stated timelines and importer licences: how an injectable vitamin product reaches registration in Malaysia.